India's Pharmaceutical Exports

Country Profile

Uzbekistan

Uzbekistan is a growing market for Indian pharmaceuticals — $120M in FY 2025–26, with 2.6× growth over the past decade. Medicines accounts for 84% of shipments, with vaccines contributing $13.6M. The compound annual growth rate since FY2015 stands at 9.2%.

🇺🇿 $120M · 2.6× growth since FY2015 · 9.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$120M
Exports FY2025–26 DGCIS
2.6×
Growth FY2015→2026
9.2%
CAGR FY2015→2026
84%
Medicines Share
5
Product Categories Supplied
Uzbekistan is a growing market for Indian pharmaceuticals — $120M in FY 2025–26, with 2.6× growth over the past decade. Medicines accounts for 84% of shipments, with vaccines contributing $13.6M. The compound annual growth rate since FY2015 stands at 9.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $100M (83.6%) Vaccines $13.6M (11.4%) Medicine Ingredients $3.57M (3.0%) Traditional & Herbal $1.45M (1.2%) Surgical & Hospital Supplies $1.05M (0.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Uzbekistan in the RBI overseas direct investment dataset (2011–2026).